Riders · Health and Human Services Commission · Article II: Health and Human Services
Medicaid Reimbursement Rates for Rapid Testing
Rider 148 in the House passed, page II-94
This rider is not in the Conference or any later version.
Through the session
- 2024-25 Act Not in this version
- Introduced (Senate) Not in this version
- Introduced (House) Not in this version
- Senate substitute Not in this version
- House substitute New rider 148
- House passed Unchanged rider 148
- Conference Dropped
- 2026-27 Act Not in this version
Pick any two steps to compare their wording.
What changed in the text
House substitute → House passed: the same text in both versions.
Removed words are struck through; added words are underlined. Sources: House substitute · House passed.
Every version: numbers, statuses and source pages
| Version | Rider | Against the version before | Against the current budget | Source |
|---|---|---|---|---|
| 2024-25 ActGeneral Appropriations Act, 2024-25 Biennium | Not in this version | |||
| Introduced (Senate)Senate Bill 1 as introduced (LBB recommended, Senate) | Not in this version | |||
| Introduced (House)House Bill 1 as introduced (LBB recommended, House) | Not in this version | |||
| Senate substituteCommittee Substitute for Senate Bill 1 | Not in this version | |||
| House substituteHouse Committee Substitute for Senate Bill 1 | 148 | New | New | Page II-93 |
| House passedSenate Bill 1 as passed the second house | 148 | Unchanged | New | Page II-94 |
| ConferenceConference Committee Report for Senate Bill 1 | Not in this version | |||
| 2026-27 ActGeneral Appropriations Act, 2026-27 Biennium | Not in this version | |||
Full text of each wording
House substitute, House passed
Source, page II-94Medicaid Reimbursement Rates for Rapid Testing. It is the intent of the Legislature that the Health and Human Services Commission (HHSC) shall evaluate the rate for reimbursement for services related to syphilis testing and treatment to include accurate reimbursement for both point of care rapid testing and best practices for most effective treatment of syphilis no later than October 1, 2025. HHSC shall consider clinical expertise, public comments, the characteristics of the populations served, and financial sustainability of reimbursement rates prior to adopting final rates.